Elizabeth Bayliss to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Elizabeth Bayliss has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.128
-
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial. Ann Oncol. 2016 05; 27(5):806-12.
Score: 0.128